SeekingAlpha · Nov 17, 2026
PJP: Healthcare Sector Dashboard For November
Analyst sees Invesco Pharmaceuticals ETF as a long-term or tactical option; it beat XLV in the past year but lagged from July 2015 to July 2025.
NYSE · XPH
Financial Services · Asset Management
$63.42
Down-$1.12 (-1.76%)
Updated Nov 20, 2026, 8:06 PM
SID Score
4.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · XPH
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 19, 2026
XPH closed at $63.42 after 21 trading sessions, down 1.34% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | $64.14 | $64.39 | $63.10 | $63.42 | 301.26K |
| Nov 18, 2026 | $64.18 | $65.09 | $64.18 | $64.23 | 258.27K |
| Nov 17, 2026 | $64.74 | $65.18 | $63.82 | $64.16 | 105.13K |
| Nov 16, 2026 | $66.85 | $67.14 | $65.205 | $65.36 | 78.6K |
| Nov 13, 2026 | $67.02 | $67.12 | $65.7501 | $66.83 | 52.97K |
| Nov 12, 2026 | $68.67 | $68.67 | $66.94 | $67.02 | 70.7K |
| Nov 11, 2026 | $68.00 | $68.88 | $67.8334 | $68.82 | 72.22K |
| Nov 10, 2026 | $66.77 | $68.09 | $66.77 | $67.93 | 174.11K |
| Nov 9, 2026 | $65.73 | $67.45 | $65.05 | $67.37 | 639.88K |
| Nov 6, 2026 | $62.965 | $65.05 | $62.965 | $64.75 | 171.09K |
| Nov 5, 2026 | $65.85 | $66.23 | $62.60 | $62.65 | 254.5K |
| Nov 4, 2026 | $65.55 | $65.655 | $63.90 | $65.36 | 192.78K |
| Nov 3, 2026 | $64.03 | $65.12 | $64.03 | $64.30 | 728.35K |
| Nov 2, 2026 | $64.91 | $65.3499 | $63.51 | $63.61 | 780.63K |
| Oct 30, 2026 | $65.32 | $65.71 | $64.44 | $64.80 | 230.63K |
| Oct 29, 2026 | $65.31 | $66.01 | $64.6514 | $65.18 | 227.7K |
| Oct 28, 2026 | $63.42 | $64.55 | $63.42 | $64.55 | 95.28K |
| Oct 27, 2026 | $62.89 | $63.96 | $62.79 | $63.96 | 50.94K |
| Oct 26, 2026 | $62.83 | $63.35 | $62.70 | $62.90 | 44.84K |
| Oct 23, 2026 | $63.98 | $63.98 | $62.4592 | $62.70 | 39.85K |
| Oct 22, 2026 | $64.00 | $64.98 | $63.84 | $64.28 | 141.9K |
The latest Smart Investors Daily articles mentioning XPH.
Company
Market Activity
Research & News
XPH research
Company profile and research snapshot.
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Nov 17, 2026
Analyst sees Invesco Pharmaceuticals ETF as a long-term or tactical option; it beat XLV in the past year but lagged from July 2015 to July 2025.
Yahoo · Nov 13, 2026
BioNTech has multiple catalysts that could generate a rally of 35% for the stock.
Yahoo · Oct 21, 2026
Smart Beta ETF report for XPH
SeekingAlpha · Oct 16, 2026
SPDR S&P Pharmaceuticals ETF offers diversified pharma exposure with low company-specific risk due to its modified equal-weight methodology. Read more on XPH.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning XPH.